RVOT3V79
RVOT3V79
RVOT3V79
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
hyperactivity disorder in children and adolescents: safety considerations.<br />
Drug Saf. 2007;30(1):17-26.<br />
166 Conners CK, Taylor E. Pemoline, methylphenidate, and placebo in<br />
children with minimal brain dysfunction. Arch Gen Psychiatry. 1980<br />
Aug;37(8):922-30.<br />
167 Greenhill LL, Findling RL, Swanson JM. A double-blind, placebocontrolled<br />
study of modified-release methylphenidate in children with<br />
attention-deficit/hyperactivity disorder. Pediatrics. 2002 Mar;109(3):E39.<br />
168 Findling RL, Quinn D, Hatch SJ, Cameron SJ, DeCory HH, McDowell<br />
M. Comparison of the clinical efficacy of twice-daily Ritalin and oncedaily<br />
Equasym XL with placebo in children with Attention Deficit/Hyperactivity<br />
Disorder. Eur Child Adolesc Psychiatry. 2006 Dec;15(8):<br />
450-9.<br />
169 Ialongo NS, López M, Horn WF, Pascoe JM. Effects of psychostimulant<br />
medication on self-perceptions of competence, control, and mood<br />
in children with attention deficit hyperactivity disorder. J Clin Child<br />
Psychol. 1994 Jun;23(2):161-73.<br />
170 Pliszka SR, Browne RG, Olvera RL, Wynne SK. A double-blind, placebo-controlled<br />
study of Adderall and methylphenidate in the<br />
treatment of attention-deficit/hyperactivity disorder. J Am Acad Child<br />
Adolesc Psychiatry. 2000 May;39(5):619-26.<br />
171 Kurlan R, Goetz CG, McDermott MP. Treatment of ADHD in children<br />
with tics: a randomized controlled trial. Neurology. 2002;58:527-<br />
36.<br />
172 Greenhill LL, Muniz R, Ball RR, Levine A, Pestreich L, Jiang H. Efficacy<br />
and safety of dexmethylphenidate extended-release capsules in<br />
children with attention-deficit/hyperactivity disorder. J Am Acad Child<br />
Adolesc Psychiatry. 2006 Jul;45(7):817-23.<br />
173 Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill L, Lerner<br />
M, et al. Multisite controlled study of OROS methylphenidate in<br />
the treatment of adolescents with attention-deficit/hyperactivity disorder.<br />
Arch Pediatr Adolesc Med. 2006 Jan;160(1):82-90.<br />
174 Lerer RJ, Lerer MP, Artner J. The effects of methylphenidate on the<br />
handwriting of children with minimal brain dysfunction. J Pediatr. 1977<br />
Jul;91(1):127-32.<br />
175 Palumbo D, Spencer T, Lynch J, Co-Chien H, Faraone SV. Emergence<br />
of tics in children with ADHD: impact of once-daily OROS methylphenidate<br />
therapy. J Child Adolesc Psychopharmacol. 2004;14(2):185-<br />
94.<br />
176 Poncin Y, Sukhodolsky DG, McGuire J, Scahill L. Drug and non-drug<br />
treatments of children with ADHD and tic disorders. Eur Child Adolesc<br />
Psychiatry. 2007 Jun;16 Suppl 1:78-88.<br />
184 GuíaS DE PráCtICa CLíNICa EN EL SNS